These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2928717)

  • 1. [Recurrent oxalo-calcium lithiasis. 1: Epidemiology, composition and theories of calculi formation: crystallization factors].
    Reveillaud RJ; Daudon M
    Rev Prat; 1989 Jan; 39(2):141-8. PubMed ID: 2928717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fundamental bases of urinary oxalo-calcic lithogenesis].
    Robert M; Averous M
    J Urol (Paris); 1994; 100(1):40-2. PubMed ID: 8089531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent oxalocalcium lithiasis. 2: Risk factors and prevention of recurrence of calcium urinary lithiasis].
    Réveillaud RJ; Daudon M
    Rev Prat; 1989 Feb; 39(4):317-23. PubMed ID: 2649970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of urinary lithiasis in our Unit. Clinical course in time and predictive factors].
    Arias Fúnez F; García Cuerpo E; Lovaco Castellanos F; Escudero Barrilero A; Avila Padilla S; Villar Palasí J
    Arch Esp Urol; 2000 May; 53(4):343-7. PubMed ID: 10900764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uric acid and oxalate lithiasis. Physico-chemical and crystallo-chemical explanation of the relationship].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):211-21. PubMed ID: 7434985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation.
    Rodgers A
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S351-4. PubMed ID: 10541262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relative risk periods for calcium oxalate stone formation: the circadian rhythm of formation in urine].
    Deng YL
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):555-8, 574. PubMed ID: 3243151
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physicochemical quality of drinking water in Southern Algeria: study of excess mineral salts].
    Djellouli HM; Taleb S; Harrache-Chettouh D; Djaroud S
    Sante; 2005; 15(2):109-12. PubMed ID: 16061448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrastructural study of urinary lithiasis. Oxalo-calcic lithiasis. I: Helicoid fibers].
    Alonso JJ; Jiménez Cruz JF; Millán MC; Mayordomo F; Valls F
    Arch Esp Urol; 1985; 38(5):439-43. PubMed ID: 4083925
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.
    Koutsoukos PG; Sheehan ME; Nancollas GH
    Invest Urol; 1981 Mar; 18(5):358-63. PubMed ID: 7203960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic investigation of calcium oxalate urinary lithiasis. Indicators of lithogenic risk: modalities, applications and perspectives].
    Robert M
    Prog Urol; 1996 Feb; 6(1):44-51. PubMed ID: 8624527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of metabolic disorders in patients with recurrent urinary calculi].
    Schröder HE; Lohse R; Böhm WD
    Z Urol Nephrol; 1981 Mar; 74(3):235-41. PubMed ID: 7223105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y
    Nephrologie; 1999; 20(7):363-9. PubMed ID: 10642984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
    Khan SR
    Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.